Related Experiment Video
Updated: Apr 25, 2026

Analysis of Cell Migration within a Three-dimensional Collagen Matrix
Published on: October 5, 2014
New strategy to control cell migration and metastasis regulated by CCN2/CTGF
Diego Pinheiro Aguiar1, Gabriel Correa de Farias1, Eduardo Branco de Sousa1
1Research Division, National Institute of Traumatology and Orthopedics, Rio de Janeiro, RJ, Brazil.
Abstract:
Connective tissue growth factor (CTGF)/CCN family member 2 (CCN2) is a CCN family member of matricellular signaling modulators. It has been shown that CCN2/CTGF mediates cell adhesion, aggregation and migration in a large variety of cell types, including vascular endothelial cells, fibroblasts, epithelial cells, aortic smooth muscle and also pluripotent stem cells. Others matricellular proteins are capable of interacting with CCN2/CTGF to mediate its function. Cell migration is a key feature for tumor cell invasion and metastasis. CCN2/CTGF seems to be a prognostic marker for cancer. In addition, here we intend to discuss recent discoveries and a new strategy to develop therapies against CCN2/CTGF, in order to treat cancer metastasis.
Insights
Connective tissue growth factor (CTGF), also known as CCN family member 2 (CCN2), is crucial for cell migration, a key process in cancer metastasis. This study explores new therapeutic strategies targeting CCN2/CTGF to combat cancer spread.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Connective tissue growth factor (CTGF), or CCN family member 2 (CCN2), is a matricellular signaling modulator.
- CCN2/CTGF plays a role in cell adhesion, aggregation, and migration across various cell types.
- Other matricellular proteins can interact with CCN2/CTGF to influence its functions.
Purpose of the Study:
- To discuss recent discoveries concerning CCN2/CTGF.
- To present a novel strategy for developing therapies targeting CCN2/CTGF.
- To address the role of CCN2/CTGF in cancer metastasis.
Main Methods:
- Literature review of recent discoveries on CCN2/CTGF.
- Analysis of CCN2/CTGF's role in cell migration and cancer.
- Conceptualization of new therapeutic strategies against CCN2/CTGF.
Main Results:
- CCN2/CTGF mediates critical cellular processes including migration.
- Cell migration is fundamental to tumor invasion and metastasis.
- CCN2/CTGF is implicated as a prognostic marker in cancer.
Conclusions:
- CCN2/CTGF is a significant factor in cancer metastasis.
- Targeting CCN2/CTGF presents a promising therapeutic strategy.
- Further research into CCN2/CTGF inhibitors could lead to effective cancer treatments.
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Cytoskeletal Coordination in Cell Migration

